openPR Logo
Press release

Asia-Pacific Urothelial Carcinoma Market Share, Trends, Size, Research and Forecast 2020-2026

08-12-2020 11:26 AM CET | Health & Medicine

Press release from: Orion Market Research

Asia-Pacific Urothelial Carcinoma Market Share, Trends, Size,

Asia-Pacific urothelial carcinoma market is estimated to grow at a CAGR of around 9.4% during the forecast period. The rising healthcare industry, majorly in the emerging economies of the region such as India and China, is significantly propelling the growth of the market in Asia-Pacific. A growing number of smokers in Asian economies is one of the major factors attributing to an increasing number of bladder cancer patients. The number of smokers is increasing substantially in the adult population of the region due to changing lifestyles and shifting habits towards smoking and tobacco consumption. Other factors that are considered as a significant cause of bladder cancer include radiation exposure, intake, or exposure to harmful chemicals, aging, and others. Aging is considered one of the major factors leading to bladder cancer due to the weakening of immune cells against cancer tissues in the bladder. Countries of Asia-Pacific such as Japan and China are reported to the aging population rapidly. Therefore, Asia-Pacific is comparatively more prone to bladder cancer as compared to other regions.

A full report of Asia-Pacific Urothelial Carcinoma Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-urothelial-carcinoma-market

Asia-Pacific urothelial carcinoma market is segmented into diagnosis and treatment. Based on the diagnosis, the market is segmented into cystoscopy, biopsy, urinalysis, urine cytology, intravenous pyelogram (IVP), and others. Based on treatment, the market is segmented into chemotherapy, immunotherapy, radiation therapy, surgery, and other treatment which include targeted therapy. The chemotherapy segment is expected to dominate the market in the future. This can be attributed to the fact that chemotherapy is the best alternative used to restrict the growth of cancer cells in the diseased patient. The chemotherapy is highly adopted as it kills cancer cells that are spread to other parts of the body, far from its primary tumor.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-urothelial-carcinoma-market

The companies which are contributing to the growth of the Asia-Pacific urothelial carcinoma market include AstraZeneca PLC, Bristol-Myers Squibb, Co., Eli Lilly & Co., GlaxoSmithKline PLC, Sysmex Corp., and Pfizer, Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.

Asia-Pacific Urothelial Carcinoma Market- Segmentation

By Diagnosis

• Cystoscopy
• Biopsy
• Urinalysis
• Urine Cytology
• Intravenous Pyelogram (IVP)
• Others (Biomarkers)

By Treatment

• Surgery
• Chemotherapy
• Immunotherapy
• Radiation Therapy
• Others (Targeted Therapy)

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-urothelial-carcinoma-market

Asia-Pacific Urothelial Carcinoma Market– Segment
by Region

• China
• Japan
• India
• Rest of Asia-Pacific

Company Profiles

• Astellas Pharma Inc.
• AstraZeneca PLC
• Bayer AG
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.
• Merck KGaA
• Pfizer Inc.
• Sysmex Corp.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Urothelial Carcinoma Market Share, Trends, Size, Research and Forecast 2020-2026 here

News-ID: 2110497 • Views: 182

More Releases from Orion Market Research

Mouth Ulcer Treatment Market Share, Trends, Size, Research and Forecast 2020-202 …
The global mouth ulcer treatment market is anticipated to grow with a modest growth rate during the forecast period. Mouth ulcers are painful and make the regular eating and drinking uncomfortable for the people. In addition to this, general factors such as stress & anxiety and hormonal changes can also trigger the mouth ulcer in certain patients. This generates a significant demand for mouth ulcer treatment all across the globe.
Lipid Disorder Treatment Market Size, Share, Trends, Analysis and Forecast 2020- …
The global lipid disorder treatment market is anticipated to grow with a significant CAGR of 7.5% during the forecast period. The altered lipid profiles that generally result from the defects are anticipated to greatly enhance the risk of cardiovascular disease or other complications. The growth of the lipid disorder treatment market is owing to the increasing application of advanced therapies for the correction of altered lipid levels. For instance, gene
Hemophilia Market Size, Share, Growth, Research and Forecast 2020-2026
The global hemophilia market is anticipated to grow with a significant CAGR of 6% during the forecast period. The hemophilia market growth is owing to the increasing demand for the prophylactic treatment of hemophilia. In addition to this, the increasing engagement of healthcare professionals, hemophilia treatment centers, as well as hemophilia societies to improve the care of hemophilia patients and their quality of life is also expected to drive the
Silicon Resin Market Growth, Size, Share and Forecast 2020-2026
The silicon resin market is projected to grow at a considerable CAGR of around 6% during the forecast period (2020-2026). The increasing use of silicon resins in a wide range of end-user industries including automotive, building and construction, and personal care & cosmetics among others is one of the major factors to drive the growth of the global silicon resins market. Enhanced thermal stability, weathering resistance, low surface tension, maintaining

All 5 Releases


More Releases for Urothelial

European Urothelial Carcinoma Market Research and Forecast 2020-2026
European urothelial carcinoma market is estimated to grow significantly at a CAGR of around 9.2%, during the forecast period. The growth of the market is attributed to well-developed healthcare infrastructure, significant healthcare expenditure, and growing prevalence and incidence of urothelial carcinoma across many European economies. Sedentary lifestyle such as smoking, consumption of drugs, and alcohol in European countries are the major factors for the growing incidence of urothelial carcinoma among
Urothelial Cancer Drugs - Product Modifications 2028 | Market AstraZeneca, Merck
Global Urothelial Cancer Drugs Market: Overview Urothelial carcinoma, also known as transitional cell carcinoma, is a cancerous tumor of the bladder which can spread to other parts of the body. The urothelium comprises of the lining on the inside of the bladder, urethra, and ureters. It also consists of the renal pelvis. All those comprise of the urothelial cells, or transitional cells. Urothelial carcinoma is the most widespread bladder cancer. It
Urothelial Cancer Drugs Market - Players largest contributor 2028 | Roche, Astra …
Global Urothelial Cancer Drugs Market: Overview Urothelial carcinoma, also known as transitional cell carcinoma, is a cancerous tumor of the bladder which can spread to other parts of the body. The urothelium comprises of the lining on the inside of the bladder, urethra, and ureters. It also consists of the renal pelvis. All those comprise of the urothelial cells, or transitional cells. Urothelial carcinoma is the most widespread bladder cancer. It
Urothelial Carcinoma Treatment Market to Record Study Growth by 2024
Urothelial carcinoma is a malignant neoplasm resulting from transitional epithelium, occurring mainly in the urinary bladder, renal pelves or ureters; frequently papillary. These carcinomas are classified according to the degree of anaplasia. Urothelial cell carcinoma (UCC) is a type of cancer that normally occurs in the urinary system: urinary bladder, kidney and accessory organs. It is the most common type of bladder, ureter, urethra, and urachus cancer. Urothelial cell carcinoma
Urothelial Carcinoma Diagnostics Market Forecast over 2017 – 2025
Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis. Bladder tumors account for 90-95% of urothelial carcinoma. Urothelial Carcinoma occur more commonly in men than in women with the ratio of 3:1. Tobacco smoking, Coffee drinking, analgesic abuse, some occupational exposures are the factors that promote urothelial carcinoma. The urothelial carcinoma diagnosis involves the tests that are used
Urothelial Carcinoma Treatment Market : Trends and Key Developments 2016 - 2024
Urothelial carcinoma is a malignant neoplasm resulting from transitional epithelium, occurring mainly in the urinary bladder, renal pelves or ureters; frequently papillary. These carcinomas are classified according to the degree of anaplasia. Urothelial cell carcinoma (UCC) is a type of cancer that normally occurs in the urinary system: urinary bladder, kidney and accessory organs. It is the most common type of bladder, ureter, urethra, and urachus cancer. Urothelial cell carcinoma